,Sample,Study ID,Reported Trait,Percentile
2003,002_S_4171,GCST000237,Alzheimer's Disease,
33441,052_S_0671,GCST011696,Alzheimer's Disease,1-100
73206,109_S_4260,GCST006995,Logical Memory (Delayed Recall) In Alzheimer's Disease Dementia,
28507,052_S_1346,GCST004246,Alzheimer's Disease,0-69
38902,035_S_0555,GCST009020,Alzheimer's Disease,72-98
49454,027_S_0120,GCST001026,Alzheimer's Disease (Late Onset),
13970,129_S_1246,GCST003427,Alzheimer Disease And Age Of Onset,0
27627,022_S_2167,GCST002814,Alzheimer's Disease (Apoe E4 Interaction),8
81894,941_S_1202,GCST009025,Alzheimer's Disease And/Or Vascular Dementia (Clinical Subgroup Vad+),
62376,037_S_0454,GCST90025853,Global Cognition (Clinical Dementia Rating Scale Sum Of Boxes),63
69436,014_s_4615,GCST006152,Language Impairment In Frontotemporal Lobe Dementia,73-77
32788,126_S_2405,GCST006149,Frontotemporal Dementia With Grn Mutation (Age At Onset),43-50
8654,018_S_2155,GCST001963,Alzheimer's Disease (Late Onset),
70561,131_S_0384,GCST006151,Memory Dysfunction In Frontotemporal Lobe Dementia,73-75
29638,099_S_4205,GCST004246,Alzheimer's Disease,45-61
697,006_S_4515,GCST007600,Alzheimer's Disease,81-90
26338,141_S_0915,GCST002817,Alzheimer's Disease In Apoe E4- Carriers,67
79482,067_S_4054,GCST006991,Cerebrospinal Fluid T-Tau Levels In Alzheimer's Disease Dementia,6-10
81567,116_S_4635,GCST000993,Vascular Dementia,47-100
68448,032_S_4348,GCST007334,Alzheimer's Disease With Language Domain Impairment,98
47167,011_S_4075,GCST007333,Alzheimer's Disease With No Specific Cognitive Domain Impairment,92
25502,006_S_4153,GCST002814,Alzheimer's Disease (Apoe E4 Interaction),91-93
78912,037_S_4302,GCST90020050,Psychosis In Alzheimer's Disease,38
84184,036_S_0945,GCST001835,Response To Cholinesterase Inhibitors In Alzheimer's Disease,
77772,073_S_2191,GCST006153,Parkinsonism In Frontotemporal Lobe Dementia,56-60
54919,073_s_4614,GCST010567,Rate Of Cognitive Decline In Alzheimer's Disease,99
20858,033_S_4505,GCST000980,Alzheimer's Disease (Late Onset),
31358,123_S_4526,GCST006147,Frontotemporal Dementia (Age At Onset),8
12863,035_S_4414,GCST002954,Alzheimer's Disease (Late Onset),9-21
71830,035_S_4464,GCST006994,Logical Memory (Immediate Recall) In Alzheimer's Disease Dementia,34-38
51186,031_S_4042,GCST012481,Cerebral Amyloid Angiopathy In Alzheimer's Disease,52
28966,007_S_4516,GCST004246,Alzheimer's Disease,
80387,127_S_4197,GCST001951,Alzheimer's Disease Biomarkers,87-96
59227,123_S_0298,GCST002960,Frontotemporal Dementia,18
45123,031_S_4496,GCST007318,Alzheimer's Disease With Visuospatial Domain Impairment,2
902,068_S_2168,GCST007600,Alzheimer's Disease,15-30
83230,012_S_1133,GCST007318,Alzheimer's Disease With Visuospatial Domain Impairment,72
37616,067_S_4212,GCST006990,Cerebrospinal Ab1-42 Levels In Alzheimer's Disease Dementia,31-100
10413,094_S_4503,GCST003427,Alzheimer Disease And Age Of Onset,19
70527,037_S_4015,GCST006151,Memory Dysfunction In Frontotemporal Lobe Dementia,
40899,019_S_4293,GCST009023,Alzheimer's Disease (Clinical Subgroup Ad++),
82228,135_S_4446,GCST009025,Alzheimer's Disease And/Or Vascular Dementia (Clinical Subgroup Vad+),
166,027_S_0120,GCST007600,Alzheimer's Disease,81-90
84725,068_S_4431,GCST001835,Response To Cholinesterase Inhibitors In Alzheimer's Disease,13-29
68324,037_S_4214,GCST007334,Alzheimer's Disease With Language Domain Impairment,64
34313,153_S_4139,GCST002245,Alzheimer's Disease (Late Onset),3
80440,067_S_4212,GCST001951,Alzheimer's Disease Biomarkers,
9958,130_S_2373,GCST003427,Alzheimer Disease And Age Of Onset,4
22596,141_S_2333,GCST007320,Alzheimer's Disease Or Family History Of Alzheimer's Disease,87
59793,003_S_0908,GCST006147,Frontotemporal Dementia (Age At Onset),92-95
58807,141_S_4426,GCST002516,Frontotemporal Dementia,10-51
81103,011_S_4075,GCST000993,Vascular Dementia,47-100
25286,037_S_4001,GCST002814,Alzheimer's Disease (Apoe E4 Interaction),82-89
80622,032_S_4386,GCST001951,Alzheimer's Disease Biomarkers,30
39034,130_S_0289,GCST009020,Alzheimer's Disease,
74453,024_S_2239,GCST003815,Late-Onset Alzheimer's Disease,74-75
60627,127_S_1427,GCST006148,Frontotemporal Dementia With Grn Mutation,61
41067,073_S_0746,GCST009023,Alzheimer's Disease (Clinical Subgroup Ad++),
12962,002_S_2043,GCST002983,Alzheimer's Disease (Late Onset),4-81
71225,072_S_2164,GCST006994,Logical Memory (Immediate Recall) In Alzheimer's Disease Dementia,12-33
35281,018_S_4349,GCST009496,Alzheimer's Disease (Onset Between Ages 58 And 79),48
25860,136_S_0873,GCST002817,Alzheimer's Disease In Apoe E4- Carriers,90
71304,002_S_1261,GCST006994,Logical Memory (Immediate Recall) In Alzheimer's Disease Dementia,81-95
11843,014_S_4328,GCST003427,Alzheimer Disease And Age Of Onset,59
83226,003_S_1122,GCST007318,Alzheimer's Disease With Visuospatial Domain Impairment,87
63811,012_S_4643,GCST006154,Frontotemporal Dementia,11-12
972,022_S_0096,GCST007600,Alzheimer's Disease,71-80
38273,037_S_0303,GCST001947,Alzheimer's Disease (Late Onset),
56690,109_S_2200,GCST002508,Frontotemporal Dementia,42-88
41825,022_S_4291,GCST009024,Alzheimer's Disease (Clinical Subgroup Ad+++),
25186,031_S_2233,GCST002814,Alzheimer's Disease (Apoe E4 Interaction),29-31
48191,137_S_4303,GCST007334,Alzheimer's Disease With Language Domain Impairment,14
43136,130_S_2391,GCST009026,Alzheimer's Disease And/Or Vascular Dementia (Clinical Subgroup Vad++),
35371,114_S_0378,GCST009496,Alzheimer's Disease (Onset Between Ages 58 And 79),73
40337,099_S_0291,GCST009022,Alzheimer's Disease (Clinical Subgroup Ad+),72-98
13739,136_S_0695,GCST003427,Alzheimer Disease And Age Of Onset,0
40520,127_S_2234,GCST009023,Alzheimer's Disease (Clinical Subgroup Ad++),
1402,072_S_4390,GCST007600,Alzheimer's Disease,31
38850,128_S_1408,GCST009020,Alzheimer's Disease,
8299,020_S_1288,GCST001963,Alzheimer's Disease (Late Onset),
41573,137_S_0686,GCST009024,Alzheimer's Disease (Clinical Subgroup Ad+++),
16733,129_S_4396,GCST003427,Alzheimer Disease And Age Of Onset,43
18664,033_S_1016,GCST007319,Alzheimer's Disease (Late Onset),14
24737,099_S_2063,GCST002813,Alzheimer's Disease In Apoe E4+ Carriers,25
73427,053_S_4557,GCST006995,Logical Memory (Delayed Recall) In Alzheimer's Disease Dementia,0
51558,123_S_4526,GCST012481,Cerebral Amyloid Angiopathy In Alzheimer's Disease,86
48100,068_S_4174,GCST007334,Alzheimer's Disease With Language Domain Impairment,92
30466,014_S_4079,GCST004247,Alzheimer's Disease (Apoe E4 Interaction),28-100
28714,023_S_4035,GCST004246,Alzheimer's Disease,0-69
41073,130_S_4468,GCST009023,Alzheimer's Disease (Clinical Subgroup Ad++),
54494,033_S_0734,GCST010567,Rate Of Cognitive Decline In Alzheimer's Disease,100
57734,072_S_4131,GCST002516,Frontotemporal Dementia,44-100
50293,098_S_0172,GCST006146,Behavioural Changes In Frontotemporal Lobe Dementia,31-32
10991,035_S_2061,GCST012215,Alzheimer's Disease,0
62626,033_S_4176,GCST90025853,Global Cognition (Clinical Dementia Rating Scale Sum Of Boxes),71
38867,018_S_0055,GCST009020,Alzheimer's Disease,
63910,022_S_2087,GCST90001390,Dementia With Lewy Bodies,84
73458,127_S_4604,GCST006995,Logical Memory (Delayed Recall) In Alzheimer's Disease Dementia,
69043,037_S_0588,GCST006152,Language Impairment In Frontotemporal Lobe Dementia,32-50
47876,073_S_2191,GCST007334,Alzheimer's Disease With Language Domain Impairment,67
